80
Participants
Start Date
February 29, 2012
Primary Completion Date
May 31, 2012
Study Completion Date
May 31, 2012
BI 113608
Low dose powder for oral solution
BI 113608
High dose powder for oral solution
BI 113608
Medium dose powder for oral solution
BI 113608
Low dose powder for oral solution
Placebo
Powder for oral solution
BI 113608
Low dose powder for oral solution
BI 113608
High dose powder for oral solution
BI 113608
High dose powder for oral solution
BI 113608
Medium dose powder for oral solution
BI 113608
Medium dose powder for oral solution
BI 113608
Low dose powder for oral solution
Boehringer Ingelheim Investigational Site, Mannheim
Lead Sponsor
Boehringer Ingelheim
INDUSTRY